Clinical Trials
5 trialsNCT00888615 2021-10-20
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Completed
NCT00084214 2014-03-06
STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
Synta Pharmaceuticals Corp.
Phase 1/2 Completed
NCT00522834 2014-03-04
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Synta Pharmaceuticals Corp.
Phase 3 Terminated
NCT00088088 2008-12-04
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
Synta Pharmaceuticals Corp.
Phase 1/2 Completed
NCT00087997 2006-06-20
A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas
Synta Pharmaceuticals Corp.
Phase 2 Completed